Nova Reports Record Fourth Quarter and Full Year 2016 Results
Record Full-Year Revenue of $163.9 Million
Full-Year GAAP Net Income of $9.6 Million
Record Full-Year Non-GAAP Net Income of $30.3 Million
REHOVOT, Israel, Feb. 14, 2017 /PRNewswire/ -- Nova Measuring Instruments (Nasdaq: NVMI), a leading innovator and a key provider of metrology solutions for advanced process control used in semiconductor manufacturing, today reported record financial results for the fourth quarter and full year 2016, the periods ended December 31, 2016.
Fourth Quarter 2016 Highlights:
- Record quarterly revenue of $50.2 million, up 14% sequentially and 25% year-over-year, significantly exceeding guidance of $42 to $46 million and as preannounced on January 26, 2017
- GAAP net income of $8.4 million, or $0.30 per diluted share, up 58% year-over-year on a per-share basis, exceeding guidance of $0.23 to $0.29 per share
- Non-GAAP net income of $11.7 million, or $0.42 per diluted share, up 24% sequentially and 121% year-over-year on a per-share basis, exceeding guidance of $0.31 to $0.40 per share
- Received over $10 million in XPS orders from multiple foundry customers
- Received multiple orders from leading 3D-NAND manufacturers
Full Year 2016 Highlights:
- Record full-year revenue of $163.9 million, up 10% year-over-year
- GAAP net income of $9.6 million, or $0.35 per diluted share, including non-recurring expense of $12.9 million related to royalty payment to the Israeli Office of the Chief Scientist
- Record non-GAAP net income of $30.3 million, or $1.10 per diluted share, up 44% year-over-year on a per-share basis
- Diversified customer mix yielded four customers contributing more than 10% each to the annual product revenues
GAAP Results ($K) |
|||||
Q4 2016 |
Q3 2016 |
Q4 2015 |
FY 2016 |
FY 2015 |
|
Revenues |
$50,212 |
$44,060 |
$40,022 |
$163,903 |
$148,514 |
Net Income (Loss) |
$8,364 |
$(4,778) |
$5,161 |
$9,644 |
$15,725 |
Earnings (Loss) per Diluted Share |
$0.30 |
$(0.18) |
$0.19 |
$0.35 |
$0.57 |
NON-GAAP Results ($K) |
|||||
Q4 2016 |
Q3 2016 |
Q4 2015 |
FY 2016 |
FY 2015 |
|
Net Income |
$11,719 |
$9,449 |
$5,278 |
$30,321 |
$21,030 |
Earnings per Diluted Share |
$0.42 |
$0.34 |
$0.19 |
$1.10 |
$0.76 |
A reconciliation between GAAP operating results and non-GAAP operating results is provided following the financial statements that are part of this release. Non-GAAP results exclude amortization of acquired intangible assets, net adjustments of deferred tax assets, stock-based compensation expenses, acquisition related expenses, expense related to royalty buyout agreement with the Office of the Chief Scientist and inventory write-off.
Management Comments
"The fourth quarter was an outstanding conclusion to another record year, demonstrating our ability to execute our growth plans effectively while improving our customer diversification and operational model," commented Eitan Oppenhaim, President and Chief Executive Officer of Nova. "We believe that the strong end to 2016 sets us on course for another growth year in 2017, bolstered by growing demand for our entire product portfolio, combining dimensions and materials metrology solutions. The strength of our business, as evidenced by our strong guidance for the first quarter, will continue into 2017 as we continue to secure wins from multiple customers in various industry segments."
Mr. Oppenhaim continued, "Nova's broad offering, which is embraced by our diversified customer base, allows us today to address a wider range of challenges that generate more opportunities for us to grow in 2017. During our continued growth, we have leveraged our proven business model to drive record profits, as evidenced by the significant increase in full-year non-GAAP net income. We expect to continue to benefit from our efficient business model in the coming years, leading to continued profitable growth."
2017 First Quarter Financial Outlook
Management provided an outlook for the first quarter, the period ending March 31, 2017. Based on current estimates, management expects:
- $50 million to $54 million in revenue
- $0.31 to $0.39 in diluted GAAP EPS
- $0.37 to $0.45 in diluted non-GAAP EPS
2016 Fourth Quarter Results
Total revenues for the fourth quarter of 2016 were $50.2 million, in line with the results announced on January 26, 2017. Sequentially, this represented an increase of 14% compared to the third quarter of 2016, and an increase of 25% relative to the fourth quarter of 2015.
Gross margin for the fourth quarter of 2016 was 56%, compared sequentially with gross margin of 22% in the third quarter of 2016 (which included a non-recurring expense related to royalty buyout agreement) and compared with gross margin of 52% in the fourth quarter of 2015.
Operating expenses in the fourth quarter of 2016 were $17.4 million. This is compared with $16.6 million in the third quarter of 2016 and compared with $17.3 million in the fourth quarter of 2015.
On a GAAP basis, the company reported net income of $8.4 million, or $0.30 per diluted share, in the fourth quarter of 2016. This is compared with a net loss of $4.8 million, or $0.18 per diluted share, in the third quarter of 2016. The company reported net income of $5.2 million, or $0.19 per diluted share, in the fourth quarter of 2015.
On a non-GAAP basis, which excludes amortization of acquired intangible assets, net adjustments of deferred tax assets and stock-based compensation expenses, the company reported net income of $11.7 million, or $0.42 per diluted share, in the fourth quarter of 2016. This is compared with net income of $9.4 million, or $0.34 per diluted share, in the third quarter of 2016, and compared with net income of $5.3 million, or $0.19 per diluted share, in the fourth quarter of 2015.
Cash utilization in the fourth quarter was higher than normal mainly due to the timing of shipments during the quarter, and management expects the first quarter of 2017 to include higher than normal cash generation.
2016 Full Year Results
Total revenues for 2016 were $163.9 million, an increase of 10% compared to total revenues of $148.5 million for 2015.
Gross margin in 2016 was 46%, and included $12.9 million of non-recurring expense related to royalty buyout agreement. This is compared with gross margin of 52% in 2015.
Operating expenses in 2016 were $65.1 million, compared with operating expenses of $65.5 million in 2015.
On a GAAP basis, which included $12.9 million of expense related to a royalty buyout agreement with the Office of the Chief Scientist, the company reported net income of $9.6 million, or $0.35 per diluted share, in 2016. This is compared with a net income of $15.7 million, or $0.57 per diluted share, in 2015.
On a non-GAAP basis, which excludes amortization of acquired intangible assets, net adjustments of deferred tax assets, stock-based compensation expenses, expense related to a royalty buyout agreement with the Office of the Chief Scientist and inventory write-off, the company reported net income of $30.3 million, or $1.10 per diluted share, in 2016. This is compared with net income of $21.0 million, or $0.76 per diluted share, in 2015.
Total cash reserves at the end of 2016 were $91.7 million, compared to $97.8 million at the end of 2015.
Conference Call Information
Nova will host a conference call today, February 14, 2017, at 9 a.m. Eastern Time, to discuss the financial results and future outlook. To attend the conference call, please dial one of the following teleconferencing numbers. Please begin by placing your calls five minutes before the conference call commences. If you are unable to connect using the toll-free numbers, please try the international dial-in number.
U.S. Dial-in Number: 1-888-244-2417
ISRAEL Dial-in Number: 1 80 925 8350
INTERNATIONAL Dial-in Number: 1-913-312-0966
At:
9 a.m. Eastern Time
6 a.m. Pacific Time
4 p.m. Israeli Time
Please reference conference ID 3628025
The conference call will also be webcast live from a link on Nova's website at http://ir.novameasuring.com. For those unable to participate in the conference call, there will be a replay available from a link on Nova's website at http://ir.novameasuring.com.
About Nova: Nova Measuring Instruments delivers continuous innovation by providing advanced metrology solutions for the semiconductor manufacturing industry. Deployed with the world's largest integrated-circuit manufacturers, Nova's products deliver state-of-the-art, high-performance metrology solutions for effective process control throughout the semiconductor fabrication lifecycle. Nova's product portfolio, which combines high-precision hardware and cutting-edge software, supports the development and production of the most advanced devices in today's high-end semiconductor market. Nova's technical innovation and market leadership enable customers to improve process performance, enhance products' yields and accelerate time to market. Nova acts as a partner to semiconductor manufacturers from its offices around the world. Additional information may be found at www.novameasuring.com.
Nova is traded on the NASDAQ & TASE under the symbol NVMI.
This press release provides financial measures that exclude charges for amortization of acquired intangible assets, net adjustment of deferred tax assets, stock-based compensation expenses, acquisition related expenses, expense related to royalty buyout agreement with the Office of the Chief Scientist and inventory write-off and are therefore not calculated in accordance with generally accepted accounting principles (GAAP). Management believes that these non-GAAP financial measures provide meaningful supplemental information regarding Nova's performance because they reflect our operational results and enhances management's and investors' ability to evaluate Nova's performance before charges or benefits considered by management to be outside Nova's ongoing operating results. The presentation of this non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. Management believes that it is in the best interest of its investors to provide financial information that will facilitate comparison of both historical and future results and allows greater transparency to supplemental information used by management in its financial and operational decision making. A reconciliation of each GAAP to non-GAAP financial measure discussed in this press release is contained in the accompanying financial tables.
This press release contains forward-looking statements within the meaning of safe harbor provisions of the Private Securities Litigation Reform Act of 1995 relating to future events or our future performance, such as statements regarding, but are not limited to, anticipated growth opportunities and projections about our business and its future revenues, expenses and profitability. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied in those forward looking statements. Factors that may affect our results, performance, circumstances or achievements include, but are not limited to, the following: our dependency on three product lines; our dependency on a small number of large customers and small number of suppliers; the highly cyclical and competitive nature of the markets we target and we operate in; our inability to reduce spending during a slowdown in the semiconductor industry; our ability to respond effectively on a timely basis to rapid technological changes; our ability to recognize the benefits of ReVera acquisition and risks that the acquisition may disrupt current plans and operations and impact relationships with customers, distributors and suppliers; our dependency on PEMs; risks related to exclusivity obligations and non-limited liability that may be included in our commercial agreements and arrangements; our ability to retain our competitive position despite the ongoing consolidation in our industry; risks related to our dependence on our manufacturing facilities; risks related to changes in our order backlog; risks related to the worldwide financial instabilities; risks related to our intellectual property; new product offerings from our competitors; unanticipated manufacturing or supply problems; risks related to government programs we participate in; risks related to taxation; changes in customer demand for our products; risks related to currency fluctuations, risks related to acquisitions we may pursue and risks related to our operations in Israel. We cannot guarantee future results, levels of activity, performance or achievements. The matters discussed in this press release also involve risks and uncertainties summarized under the heading "Risk Factors" in Nova's Annual Report on Form 20-F for the year ended December 31, 2015 filed with the Securities and Exchange Commission on February 29, 2016. These factors are updated from time to time through the filing of reports and registration statements with the Securities and Exchange Commission. Nova Measuring Instruments Ltd. does not assume any obligation to update the forward-looking information contained in this press release.
NOVA MEASURING INSTRUMENTS LTD. |
|||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS |
|||||||||
(U.S. dollars in thousands) -(Unaudited) |
|||||||||
As of December 31, |
|||||||||
ASSETS |
2016 |
2015 |
|||||||
Current assets |
|||||||||
Cash and cash equivalents |
20,406 |
27,733 |
|||||||
Short-term interest-bearing bank deposits |
70,546 |
69,298 |
|||||||
Trade accounts receivable |
42,626 |
19,046 |
|||||||
Inventories |
29,260 |
27,683 |
|||||||
Deferred tax assets |
- |
3,540 |
|||||||
Other current assets |
5,068 |
2,888 |
|||||||
Total current assets |
167,906 |
150,188 |
|||||||
Long-term assets |
|||||||||
Long-term interest-bearing bank deposits |
750 |
750 |
|||||||
Deferred tax assets |
3,020 |
5,735 |
|||||||
Severance pay funds |
1,425 |
1,514 |
|||||||
Property and equipment, net |
10,017 |
11,062 |
|||||||
Identifiable intangible assets, net |
15,361 |
17,906 |
|||||||
Goodwill |
20,114 |
20,114 |
|||||||
Total long-term assets |
50,687 |
57,081 |
|||||||
Total assets |
218,593 |
207,269 |
|||||||
LIABILITIES AND SHAREHOLDERS' EQUITY |
|||||||||
Current liabilities |
|||||||||
Trade accounts payable |
16,501 |
14,378 |
|||||||
Deferred revenues |
4,072 |
5,828 |
|||||||
Deferred tax liabilities |
- |
956 |
|||||||
Other current liabilities |
18,461 |
15,996 |
|||||||
Total current liabilities |
39,034 |
37,158 |
|||||||
Long-term liabilities |
|||||||||
Deferred tax liabilities |
1,094 |
5,760 |
|||||||
Liability for employee severance pay |
2,418 |
2,469 |
|||||||
Other long-term liabilities |
1,330 |
822 |
|||||||
Total long-term liabilities |
4,842 |
9,051 |
|||||||
Shareholders' equity |
174,717 |
161,060 |
|||||||
Total liabilities and shareholders' equity |
218,593 |
207,269 |
|||||||
NOVA MEASURING INSTRUMENTS LTD. |
||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS |
||||||||||
(U.S. dollars in thousands, except per share data) - (Unaudited) |
||||||||||
Three months ended |
Year ended |
|||||||||
December 31, |
December 31, |
|||||||||
2016 |
2015 |
2016 |
2015 |
|||||||
Revenues: |
||||||||||
Products |
39,806 |
30,581 |
122,439 |
111,178 |
||||||
Services |
10,406 |
9,441 |
41,464 |
37,336 |
||||||
Total revenues |
50,212 |
40,022 |
163,903 |
148,514 |
||||||
Cost of revenues: |
||||||||||
Products |
15,497 |
12,593 |
48,577 |
47,185 |
||||||
Services |
6,557 |
5,524 |
25,282 |
20,743 |
||||||
Expense related to royalty buyout agreement |
- |
- |
12,875 |
- |
||||||
with the Office of the Chief Scientist |
||||||||||
Inventory write-off |
- |
- |
1,889 |
- |
||||||
Amortization of acquired intangible assets in |
- |
1,051 |
- |
3,506 |
||||||
cost of products |
||||||||||
Total cost of revenues |
22,054 |
19,168 |
88,623 |
71,434 |
||||||
Gross profit |
28,158 |
20,854 |
75,280 |
77,080 |
||||||
Operating expenses: |
||||||||||
Research and development expenses, net |
9,225 |
10,826 |
34,998 |
39,703 |
||||||
Sales and marketing expenses |
5,814 |
4,474 |
20,736 |
15,768 |
||||||
General and administration expenses |
1,702 |
1,606 |
6,835 |
5,856 |
||||||
Acquisition related expenses |
- |
- |
- |
2,655 |
||||||
Amortization of acquired intangible assets |
636 |
378 |
2,545 |
1,517 |
||||||
Total operating expenses |
17,377 |
17,284 |
65,114 |
65,499 |
||||||
Operating income |
10,781 |
3,570 |
10,166 |
11,581 |
||||||
Financing income, net |
190 |
184 |
1,216 |
643 |
||||||
Income before tax on income |
10,971 |
3,754 |
11,382 |
12,224 |
||||||
Income tax expenses (benefit) |
2,607 |
(1,407) |
1,738 |
(3,501) |
||||||
Net income for the period |
8,364 |
5,161 |
9,644 |
15,725 |
||||||
Earnings per share: |
||||||||||
Basic |
0.31 |
0.19 |
0.35 |
0.58 |
||||||
Diluted |
0.30 |
0.19 |
0.35 |
0.57 |
||||||
Shares used for calculation of earnings per share: |
||||||||||
Basic |
27,292 |
27,073 |
27,175 |
27,185 |
||||||
Diluted |
27,704 |
27,334 |
27,503 |
27,510 |
NOVA MEASURING INSTRUMENTS LTD. |
|||||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS |
|||||||||
(U.S. dollars in thousands) - (Unaudited) |
|||||||||
Three months ended December 31, |
Year ended December 31, |
||||||||
2016 |
2015 |
2016 |
2015 |
||||||
Cash flows from operating activities: |
|||||||||
Net income for the period |
8,364 |
5,161 |
9,644 |
15,725 |
|||||
|
|||||||||
Depreciation |
731 |
1,288 |
4,271 |
4,597 |
|||||
Amortization of acquired intangible assets |
636 |
1,429 |
2,545 |
5,023 |
|||||
Amortization of deferred stock-based compensation |
691 |
765 |
2,735 |
2,673 |
|||||
Increase (decrease) in liability for employee termination benefits, net |
(57) |
35 |
38 |
70 |
|||||
Deferred tax assets, net |
2,028 |
(2,077) |
633 |
(5,046) |
|||||
Loss on securities |
- |
(23) |
- |
(10) |
|||||
Decrease (increase) in trade accounts receivable |
(19,068) |
4,297 |
(23,580) |
(1,959) |
|||||
Decrease (increase) in inventories |
(335) |
745 |
(1,670) |
(1,949) |
|||||
Decrease (increase) in other current and long term assets |
(1,885) |
872 |
(2,180) |
370 |
|||||
Increase in trade accounts payable |
4,127 |
1,469 |
2,123 |
1,604 |
|||||
Increase in other current liabilities and other long-term liabilities |
3,601 |
683 |
3,037 |
3,329 |
|||||
Increase (decrease) in short and long term deferred revenues |
(351) |
(1,928) |
(1,756) |
1,361 |
|||||
Net cash provided by (used in) operating activities |
(1,518) |
12,716 |
(4,160) |
25,788 |
|||||
Cash flow from investment activities: |
|||||||||
Decrease (increase) in short-term interest-bearing bank deposits |
(998) |
(10,045) |
(1,248) |
37,991 |
|||||
Proceeds from short-term held for trading securities |
- |
2,005 |
- |
2,005 |
|||||
Acquisition of subsidiary, net of acquired cash |
- |
- |
- |
(45,344) |
|||||
Additions to property and equipment |
(1,518) |
(2,205) |
(3,133) |
(4,373) |
|||||
Net cash used in investment activities |
(2,516) |
(10,245) |
(4,381) |
(9,721) |
|||||
Cash flows from financing activities: |
|||||||||
Purchases of treasury shares |
- |
- |
(937) |
(4,302) |
|||||
Shares issued under employee stock-based plans |
786 |
232 |
2,151 |
2,319 |
|||||
Net cash provided by (used in) financing activities |
786 |
232 |
1,214 |
(1,983) |
|||||
Increase (decrease) in cash and cash equivalents |
(3,248) |
2,703 |
(7,327) |
14,084 |
|||||
Cash and cash equivalents – beginning of period |
23,654 |
25,030 |
27,733 |
13,649 |
|||||
Cash and cash equivalents – end of period |
20,406 |
27,733 |
20,406 |
27,733 |
|||||
NOVA MEASURING INSTRUMENTS LTD. |
|||||
RECONCILIATION OF GAAP TO NON-GAAP RESULTS |
|||||
(U.S. dollars in thousands, except percentage and per share data) - (Unaudited) |
|||||
Three months ended |
|||||
December 31, |
September 30, |
December 31, |
|||
GAAP cost of revenues |
22,054 |
34,367 |
19,168 |
||
Amortization of acquired intangible assets in cost of products |
- |
- |
(1,051) |
||
Expense related to royalty buyout agreement with the Office of the Chief Scientist |
- |
(12,875) |
- |
||
Inventory write-off |
- |
(1,889) |
- |
||
Stock-based compensation in cost of products |
(88) |
(79) |
(94) |
||
Stock-based compensation in cost of services |
(54) |
(52) |
(63) |
||
Non-GAAP cost of revenues |
21,912 |
19,472 |
17,960 |
||
GAAP gross profit |
28,158 |
9,693 |
20,854 |
||
Gross profit adjustments |
142 |
14,895 |
1,208 |
||
Non-GAAP gross profit |
28,300 |
24,588 |
22,062 |
||
GAAP gross margin as a percentage of revenues |
56% |
22% |
52% |
||
Non-GAAP gross margin as a percentage of revenues |
56% |
56% |
55% |
||
GAAP operating expenses |
17,377 |
16,640 |
17,284 |
||
Stock-based compensation in research and development |
(247) |
(200) |
(322) |
||
Stock-based compensation in sales and marketing |
(211) |
(226) |
(213) |
||
Stock-based compensation in general and administrative |
(91) |
(82) |
(73) |
||
Amortization of acquired intangible assets |
(636) |
(637) |
(378) |
||
Non-GAAP operating expenses |
16,192 |
15,495 |
16,298 |
||
Non-GAAP operating income |
12,108 |
9,093 |
5,764 |
||
GAAP operating margin as a percentage of revenues |
21% |
(16%) |
9% |
||
Non-GAAP operating margin as a percentage of revenues |
24% |
21% |
14% |
||
GAAP tax on income |
2,607 |
(1,868) |
(1,407) |
||
Deferred tax assets adjustments, net |
(2,028) |
1,813 |
2,077 |
||
Non-GAAP tax on income |
579 |
(55) |
670 |
||
GAAP net income (loss) |
8,364 |
(4,778) |
5,161 |
||
Amortization of acquired intangible assets |
636 |
637 |
1,429 |
||
Expense related to royalty buyout agreement with the Office of the Chief Scientist |
- |
12,875 |
- |
||
Stock-based compensation expenses |
691 |
639 |
765 |
||
Deferred tax assets adjustments, net |
2,028 |
(1,813) |
(2,077) |
||
Inventory write-off |
- |
1,889 |
- |
||
Non-GAAP net income |
11,719 |
9,449 |
5,278 |
||
GAAP basic earnings (loss) per share |
0.31 |
(0.18) |
0.19 |
||
Non-GAAP basic earnings per share |
0.43 |
0.35 |
0.19 |
||
GAAP diluted earnings (loss) per share |
0.30 |
(0.18) |
0.19 |
||
Non-GAAP diluted earnings per share |
0.42 |
0.34 |
0.19 |
||
Shares used for calculation of earnings (loss) per share: |
|||||
Basic |
27,292 |
27,169 |
27,073 |
||
Diluted |
27,704 |
27,536 |
27,334 |
NOVA MEASURING INSTRUMENTS LTD. |
|||
RECONCILIATION OF GAAP TO NON-GAAP RESULTS |
|||
(U.S. dollars in thousands, except percentage and per share data) - (Unaudited) |
|||
Year ended December 31, |
|||
2016 |
2015 |
||
GAAP cost of revenues |
88,623 |
71,434 |
|
Amortization of acquired intangible assets in cost of products |
- |
(3,506) |
|
Expense related to royalty buyout agreement with the Office of the Chief Scientist |
(12,875) |
- |
|
Inventory write-off |
(1,889) |
- |
|
Stock-based compensation in cost of products |
(342) |
(373) |
|
Stock-based compensation in cost of services |
(218) |
(203) |
|
Non-GAAP cost of revenues |
73,299 |
67,352 |
|
GAAP gross profit |
75,280 |
77,080 |
|
Gross profit adjustments |
15,324 |
4,082 |
|
Non-GAAP gross profit |
90,604 |
81,162 |
|
GAAP gross margin as a percentage of revenues |
46% |
52% |
|
Non-GAAP gross margin as a percentage of revenues |
55% |
55% |
|
GAAP operating expenses |
65,114 |
65,499 |
|
Stock-based compensation in research and development |
(983) |
(1,084) |
|
Stock-based compensation in sales and marketing |
(884) |
(744) |
|
Stock-based compensation in general and administrative |
(308) |
(269) |
|
Acquisition related expenses |
- |
(2,655) |
|
Amortization of acquired intangible assets |
(2,545) |
(1,517) |
|
Non-GAAP operating expenses |
60,394 |
59,230 |
|
Non-GAAP operating income |
30,210 |
21,932 |
|
GAAP operating margin as a percentage of revenues |
6% |
8% |
|
Non-GAAP operating margin as a percentage of revenues |
18% |
15% |
|
GAAP tax on income |
1,738 |
(3,501) |
|
Deferred tax assets adjustments, net |
(633) |
5,046 |
|
Non-GAAP tax on income |
1,105 |
1,545 |
|
GAAP net income |
9,644 |
15,725 |
|
Amortization of acquired intangible assets |
2,545 |
5,023 |
|
Expense related to royalty buyout agreement with the Office of the Chief Scientist |
12,875 |
- |
|
Stock-based compensation expenses |
2,735 |
2,673 |
|
Deferred tax assets adjustments, net |
633 |
(5,046) |
|
Inventory write-off |
1,889 |
- |
|
Acquisition related expenses |
- |
2,655 |
|
Non-GAAP net income |
30,321 |
21,030 |
|
GAAP basic earnings per share |
0.35 |
0.58 |
|
Non-GAAP basic earnings per share |
1.12 |
0.77 |
|
GAAP diluted earnings per share |
0.35 |
0.57 |
|
Non-GAAP diluted earnings per share |
1.10 |
0.76 |
|
Shares used for calculation of earnings per share: |
|||
Basic |
27,175 |
27,185 |
|
Diluted |
27,503 |
27,510 |
Company Contact: |
Investor Relations Contacts: |
Dror David, Chief Financial Officer |
Hayden/ MS-IR LLC |
Nova Measuring Instruments Ltd. |
Miri Segal |
Tel: +972-73-229-5760 |
Tel: +917-607-8654 |
E-mail: [email protected] |
E-mail: [email protected] |
Or |
|
Brett Maas |
|
Tel: +646-536-7331 |
|
E-mail: [email protected] |
SOURCE Nova Measuring Instruments Ltd
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article